Other Species / Isoforms
  NBA1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S7-p
_MEVAEPssPtEEEE
0 12
NBA1 (human) _MEVAEPssPtEEEE S7-p
NBA1 (mouse) _MEVAEANsPTEEEE N7
NBA1 (rat) _MEVAEANsPtEEEE N7
S8-p
MEVAEPssPtEEEEE
0 17
NBA1 (human) MEVAEPssPtEEEEE S8-p
NBA1 (mouse) MEVAEANsPTEEEEE S8-p
NBA1 (rat) MEVAEANsPtEEEEE S8-p
T10-p
VAEPssPtEEEEEEE
0 6
NBA1 (human) VAEPssPtEEEEEEE T10-p
NBA1 (mouse) VAEANsPTEEEEEEE T10
NBA1 (rat) VAEANsPtEEEEEEE T10-p
S20-p
EEEEEEHsAEPRPRt
0 2
NBA1 (human) EEEEEEHsAEPRPRt S20-p
NBA1 (mouse) EEEEEEEGEETISEP G20
NBA1 (rat) EEEEEEEGEEPISEP G21
T27-p
sAEPRPRtRsNPEGA
0 17
NBA1 (human) sAEPRPRtRsNPEGA T27-p
NBA1 (mouse) ISEPRPHTRsNPEGA T31
NBA1 (rat) ISEPRPHTRSNPEGA T32
S29-p
EPRPRtRsNPEGAED
Upstream
Downstream
1 272
NBA1 (human)
S29-p
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • DNA repair, induced
Kinase, in vitro:
  • Akt1 (human)
Putative in vivo kinases:
  • Akt1 (human)
Treatment
  • adriamycin
  • EGF
  • gefitinib
  • MK-2206
  • NU7441
  • rapamycin
  • Su11274
  • Torin1
  • wortmannin
view more >
NBA1 (human) EPRPRtRsNPEGAED S29-p
NBA1 (mouse) EPRPHTRsNPEGAED S33-p
NBA1 (rat) EPRPHTRSNPEGAED S34
R37-m1
NPEGAEDrAVGAQAs
0 1
NBA1 (human) NPEGAEDrAVGAQAs R37-m1
NBA1 (mouse) NPEGAEDRALGAQAs R41
NBA1 (rat) NPEGAEDRAIGAQAN R42
S44-p
rAVGAQAsVGsRsEG
0 14
NBA1 (human) rAVGAQAsVGsRsEG S44-p
NBA1 (mouse) RALGAQAsVGSRsEG S48-p
NBA1 (rat) RAIGAQANVGSRsEG N49
S47-p
GAQAsVGsRsEGEGE
0 5
NBA1 (human) GAQAsVGsRsEGEGE S47-p
NBA1 (mouse) GAQAsVGSRsEGEGE S51
NBA1 (rat) GAQANVGSRsEGEGE S52
S49-p
QAsVGsRsEGEGEAA
Upstream
0 72
Treatment
  • wortmannin
NBA1 (human) QAsVGsRsEGEGEAA S49-p
NBA1 (mouse) QAsVGSRsEGEGEAA S53-p
NBA1 (rat) QANVGSRsEGEGEAA S54-p
S57-p
EGEGEAAsADDGsLN
0 9
NBA1 (human) EGEGEAAsADDGsLN S57-p
NBA1 (mouse) EGEGEAAtADGGAAS T61-p
NBA1 (rat) EGEGEAATADDGAAS T62
S62-p
AAsADDGsLNtsGAG
0 11
NBA1 (human) AAsADDGsLNtsGAG S62-p
NBA1 (mouse) AAtADGGAASVPGAG A66
NBA1 (rat) AATADDGAASVPGAV A67
T65-p
ADDGsLNtsGAGPks
0 5
NBA1 (human) ADDGsLNtsGAGPks T65-p
NBA1 (mouse) ADGGAASVPGAGPKP V69
NBA1 (rat) ADDGAASVPGAVPKP V70
S66-p
DDGsLNtsGAGPksW
Upstream
0 32
Treatment
  • antibody
  • AZD1152
  • ZM447439
view more >
NBA1 (human) DDGsLNtsGAGPksW S66-p
NBA1 (mouse) DGGAASVPGAGPKPW P70
NBA1 (rat) DDGAASVPGAVPKPW P71
K71-ub
NtsGAGPksWQVPPP
0 1
NBA1 (human) NtsGAGPksWQVPPP K71-ub
NBA1 (mouse) SVPGAGPKPWQVPAS K75
NBA1 (rat) SVPGAVPKPWQVPAP K76
S72-p
tsGAGPksWQVPPPA
0 1
NBA1 (human) tsGAGPksWQVPPPA S72-p
NBA1 (mouse) VPGAGPKPWQVPASA P76
NBA1 (rat) VPGAVPKPWQVPAPA P77
T86-p
APEVQIRtPRVNCPE
0 2
NBA1 (human) APEVQIRtPRVNCPE T86-p
NBA1 (mouse) ASEVQIRTPRVNCPE T90
NBA1 (rat) ASEVQIRTPRVNCPE T91
S112
MSLPKLESFNGSkTN
0 1
NBA1 (human) MSLPKLESFNGSkTN S112
NBA1 (mouse) MSVPKLEsFNGSRTN S116-p
NBA1 (rat) MSVPKLESFNGSRTN S117
K117-ub
LESFNGSkTNALNVs
Upstream
0 11
Treatment
  • MG132
NBA1 (human) LESFNGSkTNALNVs K117-ub
NBA1 (mouse) LEsFNGSRTNALNVS R121
NBA1 (rat) LESFNGSRTNALNVS R122
S124-p
kTNALNVsQkMIEMF
0 1
NBA1 (human) kTNALNVsQkMIEMF S124-p
NBA1 (mouse) RTNALNVSQKMVEMF S128
NBA1 (rat) RTNALNVSQKMVEMF S129
K126-ub
NALNVsQkMIEMFVR
0 3
NBA1 (human) NALNVsQkMIEMFVR K126-ub
NBA1 (mouse) NALNVSQKMVEMFVR K130
NBA1 (rat) NALNVSQKMVEMFVR K131
K233
FSLTEPMKKMFQCPY
0 1
NBA1 (human) FSLTEPMKKMFQCPY K233
NBA1 (mouse) FSLTEPMkKMFQCPY K237-ub
NBA1 (rat) FSLTEPMKKMFQCPY K238
T252-p
VVYIHNGtEEKEEEM
0 1
NBA1 (human) VVYIHNGtEEKEEEM T252-p
NBA1 (mouse) IVYIHNGTEEKEEDM T256
NBA1 (rat) IIYIHSGPEEKEDDM P257